prostate cancer

This expert panel discussion at the Southwest Prostate Cancer Symposium explores how prostate cancer screening and diagnostic decisions are made in real clinical practice. The conversation begins by discussing historical prostate-specific antigen (PSA) thresholds and why PSA alone is...

08:00 What Happens After an Elevated PSA In this episode, Dr. Rena Malik, MD and Dr. Scott Eggener explore the complexities of prostate cancer screening, discussing personalized risk assessment, PSA testing, and the evolving guidelines on when to start and stop screening. They break down...

In this insightful presentation, Dr. Leon Telis examines the evolving evidence behind testosterone replacement therapy (TRT) in men with prostate cancer. Once considered unsafe, TRT is now supported by growing research showing that it can be both safe and beneficial for select patients...

True powerhouse here! In this lecture from the 7th International Prostate Cancer Symposium, Dr. Arthur L. Burnett II presents an in depth exploration of real time intraoperative neuromonitoring during radical prostatectomy. Dr. Burnett discusses how functional nerve mapping and...

In this edition of EAUTV on Day 3 at EAU26 in London, our panel of experts discussed prostate cancer screening and AI-assisted diagnosis. Moderator Prof. Veeru Kasivisvanathan (GB) and Dr. Sigrid Carlsson (DE), Prof. Jonas Hugosson (SE), Dr. Maarten de Rooij (NL) discussed the Gothenburg study...

One of the true heavyweights in the field here! https://cancer.umn.edu/staff/emmanuel-antonarakis https://www.urotoday.com/video-lectures/advanced-prostate-cancer/video/5408-practical-approaches-to-genetic-testing-in-metastatic-hormone-sensitive-prostate-cancer-emmanuel-antonarakis.html...

Prostate Cancer Detection Statistics In the United States, approximately 333,830 men receive new prostate cancer diagnoses annually, with around 36,320 deaths from the disease. Early detection is critical to prevent identifying cancer at advanced stages, which worsens outcomes. Traditional...

Are you up to speed on emerging biomarkers? Join our expert panel to learn more about their clinical relevance and testing best practices

Conclusions

Stop wasting your time on those kiddie forums, Nelson's house is where it's at! Dr. Omer Raheem Agenda Conclusions

Dr. Morgentaler's wife! In this episode of the Dr. Geo Prostate Podcast, Dr. Geo speaks with psychologist and certified sex therapist Dr. Maryanne Brandon about how technology, porn, and AI are reshaping intimacy and contributing to a global decline in sex, including effects on young men’s...

Chapters 1:18 What are the implications of the NEJM's new paper on PSA? 5:28 At what age should most men be getting their PSA checked? 7:56 What is the usual "next step" following a high PSA reading? 10:52 What exactly does a high PSA signify? Does it always mean cancer? 14:24 Alex's conclusions

* With more than 40 years of experience, Dr. Burnett has helped shape modern men’s health, pioneering nerve-sparing prostate surgery, advancing nitric oxide research that paved the way for treatments like Viagra, and mentoring physicians around the world...

In this conversation, Vindog, also known as Vincent LeVine, shares his personal journey with prostate cancer, detailing the initial diagnosis, the emotional turmoil that followed, and the various treatment options he considered. He emphasizes the importance of PSA testing and early screening...

Is the biopsy needle more dangerous than the cancer itself? In this episode, Dr. Geo sits down with Dr. Mark Emberton, Dean of Medical Sciences at UCL and a global leader in urologic oncology. We dive deep into the "See and Treat" revolution—a massive shift in prostate cancer care that moves...

In this special Urology on the Beach edition of Pearls and Perspectives, host Amy Pearlman, MD, sits down with Mark L. Gonzalgo, MD, PhD, MBA, to discuss his recent appointment as chair of the Department of Urology at the University of Miami and his vision for leading a large academic urology...

* No one on the planet has published more in the area of exercise and prostate cancer on the planet than Dr. Newton and Dr. Newtons team in Australia Exercise oncology is the research and clinical application to people with cancer

* Even more surprisingly, doctors are testing a new approach in certain men with prostate cancer called bipolar androgen therapy, which switches testosterone levels between very low and very high. The idea is to use testosterone itself as a weapon to confuse and kill cancer cells that have...

In this episode, Dr. Brandon and Dr. Morgentaler talk about how emerging research suggests testosterone therapy may not only be safe but could actually help protect against aggressive prostate cancer, while also touching on practical approaches to maintaining sexual connection at midlife...

In this episode, Dr. Brandon & Dr. Morgentaler talk about the emerging evidence that testosterone therapy may be safe—and even beneficial—for men with metastatic prostate cancer. Chapters 00:11 – Testosterone Use in Metastatic Prostate Cancer Dr. Morgentaler introduces the surprising...

Testosterone Saturation Model https://www.nature.com/articles/s41443-025-01206-3 Abstract Testosterone replacement therapy (TRT) remains controversial in men with a history of prostate cancer due to historical concerns regarding oncologic safety. This scoping review aimed to...

One of the true pioneers in the field! Nitric Oxide the gaseous molecule critical for vascular health! Prostate cancer treatment and surgery often spark fears about permanent erectile dysfunction and the end of your sex life. I interviewed Dr. Arthur Burnett from Johns Hopkins to reveal...

* Shawn H. Zimberg, MD, National Director of Radiation Oncology Services at Solaris Health, in the news release.1 “Seeing these benefits persist for 4 years speaks to the durability of protection that the BioProtect Balloon Spacer provides in real-world treatment settings." Key Takeaways...

We have relied on PSA for decades, but what’s next in precision screening for prostate cancer? In this episode of BackTable Urology, Dr. Jason Hafron from the Michigan Institute of Urology joins host Dr. Ruchika Talwar to discuss the evolving role of biomarkers and artificial intelligence in...

* Dr. Carlsson asserts that prostate cancer screening is moving toward integrated, risk-adapted models, combining PSA, biomarkers, imaging, and AI to optimize outcomes for men globally. Dr. Sigrid Carlsson, MD, PhD, MPH, Head, Division of Clinical Epidemiology of Early Cancer Detection...

Prostate Cancer What's new and What's coming by Dr. Fred Saad, CQ, MD, FRCS, FCAHS, Professor and Chairman of the Department of Surgery at the University de Montreal, Holder of the Raymond Garneau Chair in Prostate Cancer Research, Director of GU Oncology and Clinical Research as well as the...

In this episode of AUANews Inside Tract, Man vs. Prostate founder, Dr. Wayne Kuang, talks with Dr. Jay Raman as they discuss the Man vs. Prostate campaign and its growing role in men’s health awareness. They explore how the movement expands the conversation beyond prostate cancer to include...

ASTRO: New therapy delays progression of recurrent prostate cancer Adding PSMA-targeting radioligand therapy to stereotactic body radiotherapy more than doubled progression-free survival in men with recurrent prostate cancer...

This video is part one of a four-part series where we review helpful screening and diagnostic tools for prostate cancer. This video highlights the basics of prostate cancer, its risk factors and how early screenings can help. Chapters 00:07: What is prostate cancer? 01:13: What are the risk...

Newest kid on the block! * The TULSA Procedure is a new solution for men with prostate disease, including prostate cancer and benign prostatic hyperplasia. It’s a minimally invasive procedure that is incision-free, radiation-free, and performed in an outpatient setting. Profound Medical...